In 2020, more than 4,300 SpaceX employees voluntarily participated in the COVID-19 antibody study co-authored by CEO Elon Musk.
This research was recently published in the journal Nature CommunicationsThe evidence shows that infected people with mild symptoms are less immune to COVID-19 than people with weaker diseases. The team behind the study found some evidence that there are specific antibody thresholds that can provide immunity, although they wrote ” […] The problems associated with preventing reinfection remain unclear. “
The authors point out that the vaccine also produces a stronger immune response compared to cases with no or almost no symptoms. They hope that this and other similar studies can help policymakers figure out how to effectively allocate the limited vaccine supply.
In April 2020, emails asked SpaceX employees to participate in research, just as Musk spread dangerous misinformation about the virus on internal company emails and Twitter. In March 2020, Musk told SpaceX employees in an email that he believes that they are more likely to die from a car accident than from COVID-1
Since then, nearly half a million Americans have died. Musk contracted COVID-19 in November 2020 and said that he had mild symptoms.
According to reports, the space flight company has its existing medical director-overseeing SpaceX’s new human flight program-to develop antibody testing programs with infectious disease experts at Harvard University and doctors at the Ragon Institute. Wall Street Journal. 30 co-authors from Massachusetts Institute of Technology, Harvard University, Beth Israel Deaconess Medical Center, Howard Hughes Medical Center, SpaceX and other companies conducted this study. This work was funded by the National Institutes of Health, Musk’s own charitable foundation, the COVID-19 vaccine promoter of the Gates Foundation, and NASA’s Space Health Transformation Institute.
The contracted employees will provide blood samples approximately every month. The authors of the paper pointed out that 92% of the volunteers were men, with a median age of 31 years, which may bias the results. The complete paper and data set are available for free on Nature’s website.